glp1 retatrutide Promises Big Weight Loss, but Safety Remains a Question Unapproved weight loss drug retatrutide

Less common but serious concerns - Acute pancreatitis has been reported with GLP-1 RAs

In another instance, it seemed that the addition of a GLP-1 medication for another SMI patient helped them better adhere to their metabolic psychiatry plan and decreased some of the noise, anxiety and fear related to eating and grocery shopping that can often be even more palpable for this patient population

May your BMI calculations stay accurate, your provider conversations stay productive, and your treatment outcomes stay exactly what the clinical trials promised.

Prioritize protein intake

You inject Thursday evening

If you have not lost at least 5% by this point, it is worth discussing dose adjustment with your provider